Results 91 to 100 of about 52,343 (271)
Medication Treatment for Opioid use Disorder and Community Pharmacy: Expanding Care during a National Epidemic and Global Pandemic [PDF]
Gerald Cochran +3 more
openalex +1 more source
ABSTRACT Loperamide is a widely used nonprescription peripherally acting opioid indicated for diarrhea. Loperamide undergoes extensive first‐pass metabolism, primarily by cytochrome (CYP) 3A and CYP2C8, with minor contributions from CYP2B6 and CYP2D6, and intestinal efflux by P‐glycoprotein (P‐gp).
Zhu Zhou +6 more
wiley +1 more source
Perspectives on addiction‐related problems in Vietnam
Abstract The article provides an overview of key substance use and addictive behaviors in Vietnam, alongside the development of addiction science, drawing from a synthesis of literature and the authors' perspectives. Over the last two decades, the primary illicit drug of concern has shifted from heroin to methamphetamine and other psychoactive ...
Nguyen Thu Trang +4 more
wiley +1 more source
Dynamic Changes in the Distribution of Hydrocodone and Oxycodone in Florida from 2006 to 2021
Background: Florida, which led the country in terms of its number of opioid-prescribing physicians, was unique during the height of the opioid epidemic because of its lax prescribing laws and high number of unregulated pain clinics.
Elena Lynn Stains +5 more
doaj +1 more source
Opioid Update, June 13, 2018 [PDF]
The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information about opioid use and Iowa’s efforts to address the national opioid ...
core
Opioid Update, July 12, 2017 [PDF]
The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information about opioid use and Iowa’s efforts to address the national opioid ...
core
Mandatory Minimum Sentencing Policies and Cocaine Use in the U.S., 1985–2013 [PDF]
Background: As of May 2017, the United States federal government renewed its prioritization for the enforcement of mandatory minimum sentences for illicit drug offenses.
Mezuk, Briana, Walker, Lauryn Saxe
core +2 more sources
Background and Purpose Riluzole, approved for amyotrophic lateral sclerosis (ALS), has a glutamate‐modulating profile favourable for mitigating opioid addiction. It reduces neuronal glutamate release and enhances glutamate reuptake, offering advantages over agents that only increase glutamate reuptake.
Ewa Galaj +7 more
wiley +1 more source
Opioid Update, May 16, 2018 [PDF]
The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information about opioid use and Iowa’s efforts to address the national opioid ...
core
Utilizing a National Wastewater Monitoring Program to Address the U.S. Opioid Epidemic: A Focus on Metro Atlanta, Georgia [PDF]
Tamara Wright, Atin Adhikari
openalex +1 more source

